Tracy Curley, CEO of iSpecimen Inc. (Nasdaq: ISPC), is excited to be part of the Sequire Biotechnology Conference on Thursday, February 2, 2023. As an online global marketplace connecting scientists in need of biospecimens for medical research with a network of healthcare specimen providers, iSpecimen is poised to make a major impact on the medical research field. Don’t miss this opportunity to learn more about the company and its role in the future of medical research.
About iSpecimen
iSpecimen (Nasdaq: ISPC) is revolutionizing the way scientists find the human biospecimens they need for medical discovery. Our cloud-based technology platform enables scientists to easily search through a federated network of hospitals, labs, biobanks, blood centers, and other healthcare organizations to quickly find the specimens and patients they need. Now, researchers can access a comprehensive online marketplace to easily connect with the healthcare providers that have access to these specimens.